Interrelationship of optical coherence tomography and multifocal visual-evoked potentials after optic neuritis

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 5, 2010, Pages 2770-2777

  Klistorner, Alexander ^a,b   Arvind, Hemamalini ^a,b   Garrick, Raymond ^c   Graham, Stuart L ^a,b   Paine, Mark ^d   Yiannikas, Con ^e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^e ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; OPTIC NERVE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REMYELINIZATION; RETINA NERVE CELL; RETINA NERVE FIBER LAYER THICKNESS; VISUAL SYSTEM PARAMETERS; ACUTE DISEASE; CONVALESCENCE; NERVE FIBER; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA GANGLION CELL; VISUAL ACUITY; VISUAL SYSTEM;

ACUTE DISEASE; ADULT; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; NERVE FIBERS; NEURONAL PLASTICITY; OPTIC NEURITIS; RECOVERY OF FUNCTION; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL PATHWAYS;

EID: 77952538032     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4577     Document Type: Article

References (61)

1. Plant GT. Optic neuritis and multiple sclerosis. Curr Opin Neurol. 2008;21:16-21.
2. Hickman SJ, Brex PA, Brierley CMH, et al. Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence. Neuroradiology. 2001;43:123-128.
3. Korsholm K, Madsen KH, Fredericksen JL, et al. Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas. Brain. 2007;130:1244-1253.
4. Sergott RC, Frohman EM, Glanzman R, Al-Sabbagh A. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci. 2007;263:3-14.
5. Foster RE, Whalen CC, Waxman SG. Reorganisation of the axonal membrane of demyelinated nerve fibres: morphological evidence. Science. 1980;210:661-663.
6. Bostock H, Sears TA. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physiol (London). 1978;280:273-301.
7. Shrager P, Simon W, Kazarinova-Noyes K. Na+ channel reorganisation in demyelinated axons. In: Waxman SG, ed. Multiple Sclerosis as a Neuronal Disease. Amsterdam: Elsevier; 2005;119-130.
8. Lassmann H. Pathology of neurons in multiple sclerosis. In: Waxman SG, ed. Multiple Sclerosis as a Neuronal Disease. Amsterdam: Elsevier Academic Press; 2005;153-164.
9. Kallenbach K, Fredericksen JL. Optical coherence tomography in optic neuritis and multiple sclerosis: a review. Eur J Neurol. 2007;14:841-849.
10. Frohman EM, Costello F, Stuve O, et al. Modeling axonal degeneration within the anterior visual system. Ann Neurol. 2008;65:26-35.
11. Menke MN, Feke GT, Trempe CL. OCT Measurements in patients with optic disc edema. Invest Ophthalmol Vis Sci. 2005;46:3807-3811.
12. Trip A, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer loss and visual disfunction in optic neuritis. Ann Neurol. 2005;58:383-391.
13. Costello F, Coupland S, Zackon D, et al. Measurement of axon loss with optical coherence tomography in patients with optic neuritis. NANOS Proc. 2005:188.
14. Klistorner A, Arvind H, Nguyen T, et al. Inflammation, demyelination and axonal loss in post-acute optic neuritis. Ann Neurol. 2008;61:325-331.
15. Costello F, Hodge W, Pan YI, et al. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler. 2008;14:893-905.
16. Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999;40:2520-2527.
17. Trip A, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage. 2006;31:286-293.
18. Fahle M, Bach M. Origin of the visual evoked potentials. In: Heckenlively JR, Arden GB, eds. Principles and Practice of Clinical Electrophysiology of Vision. Cambridge, MA: The MIT Press; 2006; 207-234.
19. Creutzfeldt O, Maekawa K, Hosli L. Forms of spontaneous and evoked postsynaptic potentials of cortical nerve cells. Prog Brain Res. 1969;31:265-273.
20. Jones SJ, Brusa A. Neurophysiological evidence for long-term repair of MS lesions: implications for axon protection. J Neurolog Sci. 2003;206:193-198.
21. Halliday AM, McDonald WI, Mushin J. Delayed visual evoked response in optic neuritis. Lancet. 1972;i:982-985.
22. McDonald WI. Pathophysiology of conduction in central nerve fibers. In: Desmedt JE, ed. Visual Evoked Potentials in Man. Oxford: Clarendon Press; 1977;427-437.
23. Klistorner A, Graham SL, Fraser C, et al. Electrophysiological evidence for heterogeneity of lesions in optic neuritis. Invest Ophthalmol Vis Sci. 2007;48:4549-4556.
24. Yiannikas C, Walsh JC. The variation of the pattern shift visual evoked response with the size of the stimulus field. Electroencephalogr Clin Neurophysiol. 1983;55:427-435.
25. Klistorner AI, Graham SL, Grigg JR, Billson FA. Multifocal topographic visual evoked potential: improving objective detection of local visual field defects. Invest Ophthalmol Vis Sci. 1998;39:937-950.
26. Klistorner A, Fraser C, Garrick R, et al. Correlation between fullfield and multifocal VEPs in optic neuritis. Doc Ophthalmol. 2008; 116:19-27.
27. Klistorner A, Arvind H, Nguyen T, et al. Multifocal VEP And OCT in optic neuritis: a topographical study of the structure-function relationship. Doc Ophthalmol. 2009;118:129-137.
28. Peterson J, Kidd D, Trapp BD. Axonal degeneration in multiple sclerosis: the histopathological evidence. In: Waxman SG, ed. Multiple Sclerosis as a Neuronal Disease. Amsterdam: Elsevier. 2005:165-184.
29. Pro MJ, Pons ME, Liebmann JM, et al. Imaging of the optic disk and retinal nerve fiber layer in acute optic neuritis. J Neurolog Sci. 2006;250:114-119.
30. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of the multiple sclerosis. Ann Neurol. 2001;50:121-127.
31. Klistorner A, Graham SL. Electroencephalogram-based scaling of multifocal visual evoked potentials: effect on intersubject amplitude variability. Invest Ophthalmol Vis Sci. 2001;42:2145-2152.
32. Graham SL, Klistorner A. The diagnostic significance of the multifocal pattern visual evoked potential in glaucoma. Curr Opin Ophthalmol. 1999;10:140-146.
33. Poinoosawmy D, Fontana L, Wu J, et al. Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry. Br J Ophthalmol. 1997;81:350-354.
34. Graham SL, Klistorner A, Grigg JR, Billson FA. Objective VEP perimetry in glaucoma: asymmetry analysis to identify early deficits. J Glaucoma. 2000;9:10-19.
35. Noval S, Contreras I, Rebolleda G, Munoz-Negrete FJ. Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta Ophthalmol Scan. 2006;84:790-794.
36. Youl BD, Turano G, Miller DH, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain. 1991;114:2437-2450.
37. Waxman SG. Altered distributions and functions of multiple sodium channel subtypes in multiple sclerosis and its models. In: Waxman SG, ed. Multiple Sclerosis as a Neuronal Disease. Amsterdam: Elsevier; 2005:101-118.
38. Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis. Brain. 2001;124:468-479.
39. ONSG. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673-1678.
40. Youl BD, Turano G, Towell AD, et al. Optic neuritis: swelling and atrophy. Electroencephalogr Clin Neurophysiol Suppl. 1996;46:173-179.
41. Hickman SJ, Toosy AT, Jones SJ, et al. A serial MRI study following optic nerve mean area in acute optic neuritis. Brain. 2004;127:2498-2505.
42. Lassmann H. New concepts on progressive multiple sclerosis. Cur Neurol Neurosci Rep. 2007;7:239-244.
43. Hickman SJ, Brierley CMH, Brex PA, et al. Continuing optic nerve atrophy following optic neuritis: a serial MRI study. Mult Scler. 2002;8:339-342.
44. Toosy AT, Hickman SJ, Mizszkiel KA, et al. Adaptive cortical plasticity in higher visual areas after optic neuritis. Ann Neurol. 2005; 57:622-633.
45. Fredericksen JL, Petrera J. Serial visual evoked potentials in 90 untreated patients with acute optic neuritis. Surv Ophthalmol. 1999;44(suppl):S54-S62.
46. Prineas J, Connell F. Remyelination in multiple sclerosis. Ann Neurol. 1979;5:22-31.
47. Morales Y, Parisi JE, Lucchinetti CF. The pathology of multiple sclerosis: evidence of heterogeneity. Adv Neurol. 2005;98;27-44.
48. Bruck W, Kuhlmann T, Stadelmann C. Remyelination in multiple sclerosis. J Neurol Sci. 2003;206:181-185.
49. Kornek B, Storch MK, Weissert R, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative study of axonal injury in active, inactive and remyelinated lesions. Am J Pathol. 2000;157:267-276.
50. De Groot CJA, Ruuls SR, Theeuwes JMW, et al. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol. 1997;56:10-20.
51. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma: III, quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema and toxic neuropathy. Arch Ophthalmol. 1982;100:135-146.
52. Klistorner A, Arvind H, Nguyen T, et al. Fellow eye changes in optic neuritis correlate with risk of multiple sclerosis. Mult Scler. 2009;15:928-932.
53. Mezzapesa D, Rocca M, Rodegher M, et al. Functional cortical changes of the sensomotor network are associated with clinical recovery in multiple sclerosis. Human Brain Map. 2008;29:562-573.
54. Cifelli A, Matthews PM. Cerebral plasticity in multiple sclerosis: insights from fMRI. Mult Scler. 2002;8:193-199.
55. Bjartmar C, Battistuta J, Terada N, et al. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol. 2002;51:51-58.
56. Werring DJ, Bullmore ET, Toosy AT, et al. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J Neurol Neurosurg Psychiatry. 2000;68:441-449.
57. Langkilde AR, Fredericksen JL, Rostrup E, Larsson HB. Functional MRI of the visual cortex and visual testing in patient with previous optic neuritis. Eur J Neurol. 2002;9:277-286.
58. Levin N, Orlov T, Dotan S, Zohary E. Normal and abnormal fMRI activation patterns in the visual cortex after recovery from optic neuritis. Neuroimage. 2006;33:1161-1168.
59. Fortune B, Hood DC. Conventional pattern-reversal VEPs are not equivalent to summed multifocal VEPs. Invest Ophthalmol Vis Sci. 2003;44:1367-1375.
60. Slotnick SD, Klein SA, Carney T, et al. Using multi-stimulus VEP source localization to obtain a retinotopic map of human primary visual cortex. Clin Neurophysiol. 1999;110:1793-1800.
61. Sergott RC. Optical coherence tomography: measuring in vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis. Curr Opin Ophthalmol. 2005;16:346-350.